These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polymorphism of linezolid: a combined single-crystal, powder diffraction and NMR study. Maccaroni E; Alberti E; Malpezzi L; Masciocchi N; Vladiskovic C Int J Pharm; 2008 Mar; 351(1-2):144-51. PubMed ID: 17977677 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of 1-methyl-2-nitro-5-vinylimidazole. Pelizza G; Nebuloni M; Ferrari P; Gallo GG; Pelizzi G; Tarasconi P Farmaco Sci; 1978 Jan; 33(1):3-13. PubMed ID: 620774 [TBL] [Abstract][Full Text] [Related]
6. A structural powder diffraction study of two polymorphic forms of nortriptyline hydrochloride. Vladiskovic C; Masciocchi N; Cervellino A J Pharm Sci; 2012 Dec; 101(12):4481-9. PubMed ID: 22987224 [TBL] [Abstract][Full Text] [Related]
7. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin. Malpezzi L; Magnone GA; Masciocchi N; Sironi A J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018 [TBL] [Abstract][Full Text] [Related]
8. Solid-state characterization of falicaine hydrochloride and isomorphic dyclonine hydrochloride. Part IV. Crystal polymorphism of local anaesthetic drugs. Schmidt AC Eur J Pharm Sci; 2005; 25(4-5):407-16. PubMed ID: 15896948 [TBL] [Abstract][Full Text] [Related]
9. Polymorphs and solvates of nicardipine hydrochloride. Selective stabilization of different diastereomeric racemates. Moreno-Calvo E; Muntó M; Wurst K; Ventosa N; Masciocchi N; Veciana J Mol Pharm; 2011 Apr; 8(2):395-404. PubMed ID: 21166472 [TBL] [Abstract][Full Text] [Related]
10. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy. Li Y; Chow PS; Tan RB Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601 [TBL] [Abstract][Full Text] [Related]
11. Testing the limits of sensitivity in a solid-state structural investigation by combined X-ray powder diffraction, solid-state NMR, and molecular modelling. Filip X; Borodi G; Filip C Phys Chem Chem Phys; 2011 Oct; 13(40):17978-86. PubMed ID: 21931906 [TBL] [Abstract][Full Text] [Related]
12. Molecular structure of a D-homoandrostanyl steroid derivative: single crystal and powder diffraction analyses. Martinetto P; Terech P; Grand A; Ramasseul R; Dooryhée E; Anne M J Phys Chem B; 2006 Aug; 110(31):15127-33. PubMed ID: 16884225 [TBL] [Abstract][Full Text] [Related]
13. Conformational polymorphism in bicalutamide. Vega DR; Polla G; Martinez A; Mendioroz E; Reinoso M Int J Pharm; 2007 Jan; 328(2):112-8. PubMed ID: 16978811 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide. Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III). de Armas HN; Peeters OM; Van den Mooter G; Blaton N J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation. Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515 [TBL] [Abstract][Full Text] [Related]
17. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1. Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221 [TBL] [Abstract][Full Text] [Related]